文献速递垂体与肾上腺疾病

肾上腺皮质癌:临床医生实用指南

Adrenocortical carcinoma: a practical guide for clinicians.
PubMed 文献 · Lancet Diabetes Endocrinol · 2025-03-11

本文以25个临床问题形式,结合已发表证据、两家中心60余年经验及逾1700例患者诊治体会,给出成人肾上腺皮质癌管理的个人解答与观点。

要点

  • 肾上腺皮质癌为罕见内分泌恶性肿瘤,生物学行为异质且常具侵袭性。
  • 常伴激素过多表现,如库欣综合征或男性化。
  • 诊断检查与治疗总体证据匮乏,仅米托坦获批,有经验的中心稀缺。

核心结论

  • 本文围绕成人肾上腺皮质癌临床管理最重要的25个问题,提供作者的个人解答与观点。

研究设计与样本

  • 综述:基于已发表证据、两家中心60余年集体临床经验及逾1700例患者诊治体会。

主要发现

  • 肾上腺皮质癌为罕见内分泌恶性肿瘤,管理困难的原因包括生物学行为异质且常具侵袭性、肿瘤相关激素过多、诊断检查与治疗证据总体匮乏、仅米托坦一种药物获批、有足够经验的中心稀缺。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Adrenocortical carcinoma is a rare endocrine malignancy. The management of patients with adrenocortical carcinoma is challenging for several reasons, including its heterogeneous but frequently aggressive biological behaviour; tumour-related hormonal excess (eg, Cushing's syndrome or virilisation); the overall paucity of evidence regarding diagnostic investigation and treatment; the approval of only one drug (mitotane); and the scarcity of centres with sufficient experience. In this Review, we present 25 questions on the most important aspects of the clinical management of adult patients with adrenocortical carcinoma that we have frequently asked ourselves over the past 25 years. We offer our personal answers and perspectives, drawing upon published evidence as well as more than 60 years of collective clinical experience and insights from our management of more than 1700 patients across two centres in Germany and Italy.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Fassnacht M, Puglisi S, Kimpel O, et al. Adrenocortical carcinoma: a practical guide for clinicians. Lancet Diabetes Endocrinol. 2025. PMID: 40086465. doi:10.1016/S2213-8587(24)00378-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。